The article offers information on predicting the risk of relapse in endometrial hyperplasia. Topics discussed include successful treatment for endometrial hyperplasia has been found in the form of progestogens, which modify the proliferative effects of unopposed estrogen action on the endometrium; and mentions the pre-treatment expression of progesterone receptor A (PR-A) in the endometrial glands and stroma alone can be used to predict the risk of relapse.